JP2020525407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020525407A5 JP2020525407A5 JP2019566125A JP2019566125A JP2020525407A5 JP 2020525407 A5 JP2020525407 A5 JP 2020525407A5 JP 2019566125 A JP2019566125 A JP 2019566125A JP 2019566125 A JP2019566125 A JP 2019566125A JP 2020525407 A5 JP2020525407 A5 JP 2020525407A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- per day
- subject
- composition
- crofelemer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762513251P | 2017-05-31 | 2017-05-31 | |
| US62/513,251 | 2017-05-31 | ||
| PCT/US2018/035468 WO2018222919A1 (en) | 2017-05-31 | 2018-05-31 | Methods and compositions for treating congenital diarrhea disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020525407A JP2020525407A (ja) | 2020-08-27 |
| JP2020525407A5 true JP2020525407A5 (enExample) | 2021-07-26 |
Family
ID=64455032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019566125A Pending JP2020525407A (ja) | 2017-05-31 | 2018-05-31 | 先天性下痢障害を治療するための方法及び組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11857510B2 (enExample) |
| EP (1) | EP3634581B8 (enExample) |
| JP (1) | JP2020525407A (enExample) |
| CN (1) | CN110831667A (enExample) |
| AU (1) | AU2018278312B2 (enExample) |
| CA (1) | CA3065797A1 (enExample) |
| DK (1) | DK3634581T3 (enExample) |
| ES (1) | ES2988850T3 (enExample) |
| FI (1) | FI3634581T3 (enExample) |
| IL (1) | IL270984B1 (enExample) |
| JO (1) | JOP20190275A1 (enExample) |
| WO (1) | WO2018222919A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190276A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة |
| JOP20190275A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج اضطراب إسهال خِلقي |
| WO2021257089A1 (en) * | 2020-06-19 | 2021-12-23 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0214317B1 (fr) | 1985-08-30 | 1988-08-17 | Societe Des Produits Nestle S.A. | Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation |
| US5211944A (en) | 1990-10-12 | 1993-05-18 | Shaman Pharmaceuticals, Inc. | Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
| SI9011933A (sl) | 1990-10-15 | 1998-06-30 | TANIN SEVNICA Kemična industrija p.o. | Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba |
| PT935417E (pt) | 1996-10-16 | 2009-07-17 | Napo Pharmaceuticals Inc | Formulações entéricas de composições poliméricas antidiarreicas de proantocianidina |
| US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| WO2000047062A2 (en) | 1999-02-01 | 2000-08-17 | Shaman Pharmaceuticals, Inc. | Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same |
| US7235573B2 (en) | 2002-09-30 | 2007-06-26 | The Regents Of The University Of California | Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors |
| US20070254050A1 (en) | 2006-05-01 | 2007-11-01 | Quart Barry D | Method for treatment of diarrhea-predominant irritable bowel syndrome |
| SG195538A1 (en) | 2006-05-01 | 2013-12-30 | Napo Pharmaceuticals Inc | Method for treatment of constipation-predominant irritable bowel syndrome |
| EP2529626B1 (en) | 2006-05-01 | 2017-11-22 | Napo Pharmaceuticals, Inc. | Compositions and methods for treating or preventing colon cancer |
| US20120202876A1 (en) | 2009-10-06 | 2012-08-09 | Napo Pharmaceuticals, Inc. | Methods of treating diseases with proanthocyanidin oligomers such as crofelemer |
| CN103370101A (zh) | 2010-10-31 | 2013-10-23 | 萨利克斯药品有限公司 | 用于治疗hiv相关性腹泻的方法和组合物 |
| WO2017112953A1 (en) | 2015-12-23 | 2017-06-29 | Vanessa Research, Inc. | Compositions and methods of treatment for mvid and related diseases |
| US11389424B2 (en) | 2017-03-09 | 2022-07-19 | Napo Pharmaceuticals, Inc. | Methods and compositions for treating chemotherapy-induced diarrhea |
| JOP20190276A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة |
| JOP20190275A1 (ar) | 2017-05-31 | 2019-11-27 | Napo Pharmaceuticals Inc | طرق وتركيبات لعلاج اضطراب إسهال خِلقي |
-
2017
- 2017-06-16 JO JOP/2019/0275A patent/JOP20190275A1/ar unknown
-
2018
- 2018-05-31 CN CN201880043974.4A patent/CN110831667A/zh active Pending
- 2018-05-31 EP EP18810153.9A patent/EP3634581B8/en active Active
- 2018-05-31 JP JP2019566125A patent/JP2020525407A/ja active Pending
- 2018-05-31 US US16/617,463 patent/US11857510B2/en active Active
- 2018-05-31 FI FIEP18810153.9T patent/FI3634581T3/fi active
- 2018-05-31 DK DK18810153.9T patent/DK3634581T3/da active
- 2018-05-31 CA CA3065797A patent/CA3065797A1/en active Pending
- 2018-05-31 ES ES18810153T patent/ES2988850T3/es active Active
- 2018-05-31 WO PCT/US2018/035468 patent/WO2018222919A1/en not_active Ceased
- 2018-05-31 AU AU2018278312A patent/AU2018278312B2/en active Active
-
2019
- 2019-11-27 IL IL270984A patent/IL270984B1/en unknown
-
2023
- 2023-11-27 US US18/520,464 patent/US20240325346A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim | Short-chain fatty acids in ulcerative colitis | |
| Alipoor et al. | White adipose tissue browning in critical illness: a review of the evidence, mechanisms and future perspectives | |
| JP6446134B2 (ja) | 癌幹細胞治療用組成物 | |
| JP2020525407A5 (enExample) | ||
| TR201815668T4 (tr) | Obezite tedavisine yönelik bileşikler ve bunların kullanım metotları. | |
| JP2020523375A5 (enExample) | ||
| Klein | Preventive and therapeutic efficacy of halofuginone-lactate against Cryptosporidium parvum in spontaneously infected calves: a centralised, randomised, double-blind, placebo-controlled study | |
| JP2013536859A5 (enExample) | ||
| KR20220080120A (ko) | 위장 건강 조성물 | |
| Alam et al. | Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults | |
| JP6360172B2 (ja) | チグリンアルデヒドを使用する組成物及び方法 | |
| WO2015042821A1 (zh) | 活化ampk的化合物及其使用 | |
| JP3604710B2 (ja) | 骨粗鬆症予防及び治療剤 | |
| CN104001177A (zh) | 一种治疗ii型糖尿病或代谢综合征的复方药物组合物 | |
| EP3979991B1 (en) | Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization | |
| CN115884764A (zh) | 用于治疗乙型冠状病毒感染的半胱胺前体化合物 | |
| Widjanarko et al. | Laxative potential of the konjac flour (Amorphophallus muelleri Blume) in treatment of loperamide induced constipation on Sprague Dawley rats | |
| Duvoisin et al. | Bromocriptine as an adjuvant to levodopa | |
| Kume et al. | THU0199 Tofacitinib improves left ventricular mass and cardiac output in patients with rheumatoid arthritis | |
| US9532960B2 (en) | Pharmaceutical composition and kit for applying metformin and sodium butyrate in Kras mutation cancer treatment | |
| Fior et al. | A Case of Non-Hodgkin's Lymphoma. | |
| Shelotkar et al. | A case study on Ritukala Shodhana (seasonal purification therapy) in childhood bronchial asthma | |
| JP2019218317A (ja) | 低体温の予防又は改善剤 | |
| JP2016183172A (ja) | 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤 | |
| AU629520B2 (en) | A medicament |